(-)-Blebbistatin
(Synonyms: (S)-(-)-Blebbistatin) 目录号 : GC13430(-)-Blebbistatin是外消旋体混合物(±)-Blebbistatin(货号:GC12341)的一种其中一个构型,是活性形式。(-)-Blebbistatin是一种非肌肉肌球蛋白II ATP酶的细胞渗透性抑制剂,有效抑制多种横纹肌肌球蛋白以及脊椎动物非肌肉肌球蛋白,IC50值范围为0.5-5μM,平滑肌肌球蛋白仅受到微弱抑制(IC50=80μM)。
Cas No.:856925-71-8
Sample solution is provided at 25 µL, 10mM.
(-)-Blebbistatin is one of the configurations of the racemic mixture (±)-Blebbistatin (Cat. No. GC12341) and is the active form. (-)-Blebbistatin is a cell-permeable inhibitor of non-muscle myosin II ATPase, which effectively inhibits multiple striated muscle myosins as well as vertebrate non-muscle myosins with IC50 values ranging from 0.5-5μM, and only slightly inhibits smooth muscle myosin (IC50=80μM) [1, 2]. (+)-Blebbistatinb has no effect on the ATPase activity of various myosin IIs or cell migration in cultured smooth muscle[3]. Blebbistatin is a potential photodynamic agent that can kill cancer cells. Exposure to UV light with a wavelength below 488nm can also lead to rapid inhibition of Blebbistatin [4].
In vitro, (-)-Blebbistatin (10-200μM) was used to treat five human cell lines, including F11-hTERT, U87, Du145, FEMX-I, and LNCaP, for 24h, which inhibited cell viability in a concentration-dependent manner. At the highest dose of 200μM, the survival rates of F11-hTERT cells were approximately 20%, U87 cells were 30%, and Du145, FEMX-I, and LNCaP cells were all below 10%[5]. Treatment with (-)-Blebbistatin (10μM) on intact and skinned isolated rat heart trabeculae, intact rat cardiomyocytes, and single rabbit psoas myofibrils reduced twitch force and cell shortening, decreased the contractility of trabeculae with intact membranes, without affecting tension-dependent myofilament ATPase activity[6].
References:
[1] Lucas‐Lopez C, Patterson S, Blum T, et al. Absolute Stereochemical Assignment and Fluorescence Tuning of the Small Molecule Tool,(–)‐Blebbistatin[J]. 2005.
[2] Limouze J, Straight A F, Mitchison T, et al. Specificity of blebbistatin, an inhibitor of myosin II[J]. Journal of Muscle Research & Cell Motility, 2004, 25: 337-341.
[3] Watanabe M, Yumoto M, Tanaka H, et al. Blebbistatin, a myosin II inhibitor, suppresses contraction and disrupts contractile filaments organization of skinned taenia cecum from guinea pig[J]. American Journal of Physiology-Cell Physiology, 2010, 298(5): C1118-C1126.
[4] Sakamoto T, Limouze J, Combs C A, et al. Blebbistatin, a myosin II inhibitor, is photoinactivated by blue light[J]. Biochemistry, 2005, 44(2): 584-588.
[5] Mikulich A, Kavaliauskiene S, Juzenas P. Blebbistatin, a myosin inhibitor, is phototoxic to human cancer cells under exposure to blue light[J]. Biochimica et Biophysica Acta (BBA)-General Subjects, 2012, 1820(7): 870-877.
[6] Farman G P, Tachampa K, Mateja R, et al. Blebbistatin: use as inhibitor of muscle contraction[J]. Pflügers Archiv-European Journal of Physiology, 2008, 455(6): 995-1005.
(-)-Blebbistatin是外消旋体混合物(±)-Blebbistatin(货号:GC12341)的一种其中一个构型,是活性形式。(-)-Blebbistatin是一种非肌肉肌球蛋白II ATP酶的细胞渗透性抑制剂,有效抑制多种横纹肌肌球蛋白以及脊椎动物非肌肉肌球蛋白,IC50值范围为0.5-5μM,平滑肌肌球蛋白仅受到微弱抑制(IC50=80μM)[1, 2]。(+)-Blebbistatinb对各类肌球蛋白II的ATP酶活性、培养平滑肌的细胞迁移无影响[3]。Blebbistatin是一种潜在的光动力药物,可以杀死癌细胞,暴露于波长低于488nm的UV光也可导致Blebbistatin迅速被抑制[4]。
在体外,(-)-Blebbistatin(10-200μM)处理F11-hTERT、U87、Du145、FEMX-I、LNCaP等5种人类细胞系24h,浓度依赖性地抑制了细胞活力,最高剂量200μM处理下,F11-hTERT细胞存活率约为20%,U87细胞为30%,Du145、FEMX-I和LNCaP细胞均低于10%[5]。(-)-Blebbistatin(10μM)处理完整和去皮的分离大鼠心脏小梁、大鼠完整肌细胞和单个兔腰肌肌原纤维,减少了抽搐力和细胞缩短,降低了带皮小梁的收缩力,而不影响张力依赖性肌丝ATP酶活性[6]。
Cell experiment [1]: | |
Cell lines | F11-hTERT、U87、Du145、FEMX-I、LNCaP cells |
Preparation Method | Cells were treated with 0-200µM of (-)-Blebbistatin for 3h and 24h, and cell viability was measured. |
Reaction Conditions | 0-200µM; 3、24h |
Applications | The cytotoxic effect of (-)-Blebbistatin was observed in a concentration-dependent manner when the cells were incubated for 24h. The highest dose tested (200μM for 24h) produced toxic effect with the cell viability being about 20% for the F11-hTERT cells, 30% for the U87 cells, and below 10% for the Du145, FEMX-I and LNCaP cells. |
References: |
Cas No. | 856925-71-8 | SDF | |
别名 | (S)-(-)-Blebbistatin | ||
化学名 | (S)-3a-hydroxy-6-methyl-1-phenyl-3,3a-dihydro-1H-pyrrolo[2,3-b]quinolin-4(2H)-one | ||
Canonical SMILES | O[C@@]12CCN(C3=CC=CC=C3)C1=NC4=CC=C(C)C=C4C2=O | ||
分子式 | C18H16N2O2 | 分子量 | 292.33 |
溶解度 | ≥ 14.6 mg/mL in DMSO | 储存条件 | Store at -20°C,unstable in solution, ready to use. |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.4208 mL | 17.104 mL | 34.2079 mL |
5 mM | 0.6842 mL | 3.4208 mL | 6.8416 mL |
10 mM | 0.3421 mL | 1.7104 mL | 3.4208 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet